WO2006020326A9 - Methods of identifying compounds that modulate protein activity - Google Patents

Methods of identifying compounds that modulate protein activity Download PDF

Info

Publication number
WO2006020326A9
WO2006020326A9 PCT/US2005/025762 US2005025762W WO2006020326A9 WO 2006020326 A9 WO2006020326 A9 WO 2006020326A9 US 2005025762 W US2005025762 W US 2005025762W WO 2006020326 A9 WO2006020326 A9 WO 2006020326A9
Authority
WO
WIPO (PCT)
Prior art keywords
methods
protein activity
identifying compounds
modulate protein
modulate
Prior art date
Application number
PCT/US2005/025762
Other languages
French (fr)
Other versions
WO2006020326A2 (en
Inventor
Constance Berghs
Elina Catterton
Amitabha Chaudhuri
Karen E. Ellerman
Tatiana A. Ort
Original Assignee
Curagen Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corporation filed Critical Curagen Corporation
Publication of WO2006020326A2 publication Critical patent/WO2006020326A2/en
Publication of WO2006020326A9 publication Critical patent/WO2006020326A9/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
PCT/US2005/025762 2004-08-13 2005-07-20 Methods of identifying compounds that modulate protein activity WO2006020326A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60130604P 2004-08-13 2004-08-13
US60/601,306 2004-08-13
USNONE 2006-12-21

Publications (2)

Publication Number Publication Date
WO2006020326A2 WO2006020326A2 (en) 2006-02-23
WO2006020326A9 true WO2006020326A9 (en) 2010-01-28

Family

ID=35908011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/025762 WO2006020326A2 (en) 2004-08-13 2005-07-20 Methods of identifying compounds that modulate protein activity

Country Status (1)

Country Link
WO (1) WO2006020326A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230340491A1 (en) * 2020-04-22 2023-10-26 University Of Rochester Compositions and methods for treating metabolic and cardiovascular diseases

Also Published As

Publication number Publication date
WO2006020326A2 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
EP1718308A4 (en) Methods of modulating neurotrophin-mediated activity
IL189975A0 (en) Methods of modulating neurotrophin-mediated activity
AP2007004244A0 (en) Method of modulating stress-activated protein kinase system
EP1827571A4 (en) Protein activity modification
GB0421525D0 (en) Inhibitors of protein kineses
WO2005079300A9 (en) Protein kinase inhibitors and methods for identifying same
EP1829968A4 (en) Mutant protein having peptide-production activity
AU2003299592A1 (en) Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
AU2003297700A1 (en) METHODS FOR MODULATING IKKAlpha ACTIVITY
EP1497450A4 (en) Methods for identifying compounds that modulate enzymatic activity
AU2003303520A1 (en) Irs modulators
AU2003900194A0 (en) Methods of modulating il-6
WO2007004148A8 (en) Method and system for selection of information
WO2006020326A9 (en) Methods of identifying compounds that modulate protein activity
EP1960535A4 (en) Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
WO2004088562A8 (en) Methods of specifying or identifying particulate material
WO2004056961A9 (en) Methods of identifying compounds that modulate protein activity
AU2003303381A1 (en) Methods for treating malaria by modulation of g protein function
EP1537239A4 (en) Methods of identifying compounds that modulate protein activity
AU2003293517A1 (en) Methods of determining embryo viability
AU2003206594A1 (en) Screening for modulators of pkng activity
AU2003256701A1 (en) Methods of modulating proliferative conditions
AU2004903420A0 (en) Method for the Prediction of Interaction Between Protein and Ligands
AU2004906748A0 (en) Improved Detection of Proteins
AU2004900801A0 (en) Method of pest reduction

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase

Ref document number: 05791029

Country of ref document: EP

Kind code of ref document: A2